What is CEROW's health score?

CERO THERAPEUTICS HOLDINGS, INC. (CEROW) has a TradeApes health score of 53 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CEROW's estimated fair value?

Based on our 5-year discounted cash flow model, CERO THERAPEUTICS HOLDINGS, INC.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CEROW undervalued or overvalued?

Our model currently rates CEROW as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CEROW... Refresh in a moment for the full analysis.

CERO THERAPEUTICS HOLDINGS, INC. (CEROW)

Healthcare Fair Value Medium mixed

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

50 Mixed

Operating Trend

60 Healthy

Relative Value

40 Weak

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Weak liquidity — current assets below current liabilities

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.